Payer Almanac
About the data Sign in
Star measuresDisplay measuresHEDISWhy members leave

Measures · D05 in 2023 · Part D · DD3 Member Experience with the Drug Plan

Rating of Drug Plan

Drug PlanMember ExperienceSource: CAHPS

What it measures
Percent of the best possible score the plan earned from members who rated the prescription drug plan.
How it's calculated
This case-mix adjusted measure is used to assess members' overall view of their prescription drug plan. The Consumer Assessment of Healthcare Providers and Systems (CAHPS) score uses the mean of the distribution of responses converted to a scale from 0 to 100. The score shown is the percentage of the best possible score each contract earned.
Data source
CAHPS CAHPS Survey Questions (question numbers vary depending on survey type): • Using any number from 0 to 10, where 0 is the worst prescription drug plan possible and 10 is the best prescription drug plan possible, what number would you use to rate your prescription drug plan?
Measurement period
03/2022 – 06/2022
Better when
Higher
Weight
4 (Patients’ Experience and Complaints Measure)
Star assignment
Relative Distribution and Significance Testing
Case-mix adjusted
Yes
In improvement measure
Yes
Used in CAI
No
Notes
CAHPS Survey results were sent to each contract's Medicare Compliance Officer in August 2022. These reports provide further explanation of the CAHPS scoring methodology and provide detailed information on why a specific rating was assigned.
Disaster policy
Higher measure star (2022-2023) for contracts with 25% or more enrolled affected by 2021 disasters.

From the 2023 Star Ratings Technical Notes (CMS).

Cut points over time

Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts. Dotted lines and open dots: where the cut points may move for 2028.

How the 2028 cut points are projected

Each boundary moves by its median year-on-year change since 2019. It's the same projection the Star outlook uses for every contract. CMS sets real cut points from all contracts' scores each year, so treat these as a direction, not a forecast of the exact number.

StarsOrg type2027Projected 2028Move
2★MA-PD8485+1
3★MA-PD86860
4★MA-PD87870
5★MA-PD89890
2★PDP82820
3★PDP83830
4★PDP86860
5★PDP88880

2023 star distribution

Not rated: Plan too small to be measured (159); Plan too new to be measured (130); No data available (28); Plan not required to report measure (6); Not enough data available (2)

Cut point bands

Star yearOrg type1★2★3★4★5★
2027MA-PD< 84>= 84 to < 86>= 86 to < 87>= 87 to < 89>= 89
2027PDP< 82>= 82 to < 83>= 83 to < 86>= 86 to < 88>= 88
2026MA-PD< 85>= 85 to < 86>= 86 to < 88>= 88 to < 89>= 89
2026PDP< 82>= 82 to < 83>= 83 to < 86>= 86 to < 88>= 88
2025MA-PD< 84>= 84 to < 86>= 86 to < 87>= 87 to < 89>= 89
2025PDP< 79>= 79 to < 82>= 82 to < 85>= 85 to < 87>= 87
2024MA-PD< 84>= 84 to < 85>= 85 to < 87>= 87 to < 89>= 89
2024PDP< 80>= 80 to < 81>= 81 to < 83>= 83 to < 87>= 87
2023MA-PD< 83>= 83 to < 85>= 85 to < 87>= 87 to < 88>= 88
2023PDP< 79>= 79 to < 80>= 80 to < 83>= 83 to < 87>= 87
2022MA-PD< 84>= 84 to < 85>= 85 to < 87>= 87 to < 88>= 88
2022PDP< 80>= 80 to < 82>= 82 to < 84>= 84 to < 87>= 87
2021MA-PD< 83>= 83 to < 84>= 84 to < 86>= 86 to < 87>= 87
2021PDP< 80>= 80 to < 81>= 81 to < 83>= 83 to < 87>= 87
2020MA-PD< 83? 83 to < 84? 84 to < 86? 86 to < 87? 87
2020PDP< 80? 80 to < 81? 81 to < 83? 83 to < 87? 87
2019MA-PD< 82? 82 to < 83? 83 to < 85? 85 to < 87? 87
2019PDP< 80? 80 to < 81? 81 to < 84? 84 to < 86? 86
2018MA-PD< 81? 81 to < 83? 83 to < 85? 85 to < 86? 86
2018PDP< 80? 80 to < 81? 81 to < 83? 83 to < 87? 87
2017MA-PD< 80? 80 to < 82? 82 to < 84? 84 to < 86? 86
2017PDP< 79? 79 to < 80? 80 to < 83? 83 to < 86? 86
2016MA-PD< 80? 80 to < 82? 82 to < 84? 84 to < 86? 86
2016PDP< 80? 80 to < 81? 81 to < 82? 82 to < 86? 86
2015MA-PD< 82%? 82% to < 83%? 83% to < 84%? 84% to < 87%? 87%
2015PDP< 80%? 80% to < 81%*? 81% to < 86%? 86%

Lowest-scoring contracts, 2023

ContractParentMembersScoreStarsΔShortfall to 4★Pctile
S2874 HumanaHumana Inc.—731−1100%
H2836 Anthem Blue Cross and Blue ShieldElevance Health, Inc.2,426771—100%
H6067 CareFirst BlueCross BlueShield Medicare AdvantageCareFirst, Inc.—781—90%
H8552 Anthem Blue Cross Life and Health Insurance CompanyElevance Health, Inc.1,065791−280%
H5991 EmblemHealthEmblemHealth, Inc.2,285801071%
H3152 Aetna MedicareCVS Health Corporation30,674801−171%
H4213 Arkansas Blue MedicareUSAble Mutual Insurance Company2,258801071%
H2134 Wellcare by AllwellCentene Corporation—811—61%
H1732 ANTHEM BLUE CROSS AND BLUE SHIELD HPElevance Health, Inc.—811—61%
H8432 Anthem Blue Cross and Blue Shield HPElevance Health, Inc.43,447811061%
H9431 Aetna MedicareCVS Health Corporation666811061%
H3047 WellcareCentene Corporation—811—61%
H5435 UnitedHealthcareUnitedHealth Group, Inc.1,420811061%
H3307 UnitedHealthcareUnitedHealth Group, Inc.—811061%
H4829 UnitedHealthcareUnitedHealth Group, Inc.—811—61%
S3375 BlueCross BlueShield: Empire, Excellus, WNY & NENYElevance Health, Inc.—751—82%
S8182 AmerigroupElevance Health, Inc.—751082%
H1914 WellcareCentene Corporation10,826821053%
H1894 WellpointElevance Health, Inc.2,322822+153%
H4868 WellcareCentene Corporation39,248822053%
R3332 Florida BlueGuidewell Mutual Holding Corporation—821−153%
H1659 UnitedHealthcareUnitedHealth Group, Inc.2,487821−253%
H5989 Healthfirst Medicare PlanHealthfirst, Inc.12,756822—53%
H3471 Health Alliance NorthwestThe Carle Foundation—821−253%
H3748 Aetna MedicareCVS Health Corporation4,321821053%

History

Star yearCodeNameMeasuredWeightSource
2027D05Rating of Drug Plan03/2026 – 06/20262CAHPS
2026D05Rating of Drug Plan03/2025 – 05/20252CAHPS
2025D05Rating of Drug Plan03/2024 – 06/20244CAHPS
2024D05Rating of Drug Plan03/2023 – 06/20234CAHPS
2023D05Rating of Drug Plan03/2022 – 06/20224CAHPS
2022D05Rating of Drug Plan03/2021 – 05/20212CAHPS
2021D07Rating of Drug Plan03/2019 – 05/20192CAHPS
2020D07Rating of Drug Plan03/2019 – 05/20191.5CAHPS
2019D07Rating of Drug Plan03/2018 – 06/20181.5CAHPS
2018D08Rating of Drug Plan03/2017 – 06/20171.5CAHPS
2017D08Rating of Drug Plan02/2016 – 08/20161.5CAHPS
2016D08Rating of Drug Plan02/15/2015 - 05/31/20151.5CAHPS
2015D06Rating of Drug Plan02/15/2014 - 05/31/20141.5CAHPS